- External Beam Radiation Therapy
- Internal Beam Radiation Therapy
Radiation Oncology Market size was valued at USD 6,912.3 million in 2022 and is poised to grow at a significant CAGR of 5.6% over 2023-2029. Radiation oncology, usually referred to as radiation therapy, is a form of cancer treatment in which cancer cells are eradicated using powerful energy beams. By eliminating the genetic material that regulates a cell's growth, it harms the cells. A variety of disciplines are used in the treatment of cancer. The procedure uses high-energy X rays (photons), which are typically delivered using a linear accelerator. The technical progress of radiotherapy equipment, the global rise in cancer incidence, and the rising usage of radiation therapy in oncology treatment are key drivers driving the market. The FDA just authorised Vision RT Ltd.'s DoseRT, an upgraded multi-camera system to monitor both beam and patient placement in real time during radiation, in November 2021. Similarly, in December 2020, the FDA approved Beam Site, a single camera system. Dartmouth and Norris Cotton Cancer Center collaborated on this technology, which collects photos and real-time video of the beam and allows radiation doctors to see therapy delivery in patients. These developments have boosted the radiation oncology business while also enhancing the safety and effectiveness of radiotherapy. Additionally, the radiation oncology industry is experiencing growing demand for radiotherapy as the worldwide cancer burden rises. According to the Globocan 2020 study, around 19.3 million people worldwide were suffering from cancer, with 10.0 million dying as a result. Moreover, the WHO in Europe anticipated that 4.6 million new people were diagnosed with various cancer indications such as prostate, breast, lung, colorectal, and brain in 2020, and that 2.1 million people died from the disease across European nations. According to The American Cancer Society's 2022 report, breast cancer is the most frequent ailment, accounting for around 3.0 lakh and 51,400 new instances of aggressive and non-invasive breast cancers in the United States, respectively.
Radiation Oncology Market Key Developments:
In April 2022, Elekta and GE Healthcare teamed to make precision radiation treatment options more accessible. This would allow the two firms to give hospitals with a full offering of cancer imaging and therapy.
Study Period
2024-2030Base Year
2023CAGR
5.6%Largest Market
Asia PacificFastest Growing Market
North America
Globally, the number of cancer sufferers is steadily growing. Cancer was the world's second leading cause of death in 2020, accounting for 10 million fatalities, according to the WHO. Each year, cancer kills an estimated 9.6 million people (one out of every six). According to the American Institute for Cancer Research, around 18 million cancer cases were reported worldwide in 2018. As a result, the growing number of cancer patients is propelling the worldwide radiation treatment market.
By Type
By Application
By Geography
Breast Cancer sub-segment of the application-wise industry acquired the maximum share of the global radiation oncology Market in 2021.
The market's key players, like Panacea Medical Technologies, have started taking certifications on the latest technologies, making them reliable.
North America will provide more business opportunities for the Global Radiation Oncology Market in the future.
Super specialty hospitals and radiotherapists are the primary customers in the global radiation oncology market.
1. Executive Summary |
2. Global Radiation Oncology Market Introduction |
2.1. Global Radiation Oncology Market – Taxonomy |
2.2. Global Radiation Oncology Market – Definitions |
2.2.1. Type |
2.2.2. Application |
2.2.3. Region |
3. Global Radiation Oncology Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Radiation Oncology Market Dynamic Factors - Impact Analysis |
3.6. Impact of COVID 19 on The Market |
3.7. Three Forecast Scenarios - Pessimistic, Conservative and Opportunistic |
3.8. Mapping Market Players Activities |
3.9. Recent Key Developments |
3.10. Financial Status of the Market Players |
3.11. Recent Acquisitions, Collaborations and Mergers |
4. Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Radiation Oncology Market Forecast, By Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
5.1. External Beam Radiation Therapy |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Internal Beam Radiation Therapy |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Radiation Oncology Market Forecast, By Application, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.1. Prostate Cancer |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Breast Cancer |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Lung Cancer |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Head and Neck Cancer |
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Colorectal Cancer |
6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
6.6. Cervical Cancer |
6.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.6.3. Market Opportunity Analysis |
6.7. Gynecological Cancer |
6.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.7.3. Market Opportunity Analysis |
6.8. Other |
6.8.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.8.3. Market Opportunity Analysis |
6.8.4. |
7. Global Radiation Oncology Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Distribution Channel, Distribution Channel, and Region, 2023 - 2029 |
8. North America Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
8.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
8.1.1. External Beam Radiation Therapy |
8.1.2. Internal Beam Radiation Therapy |
8.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
8.2.1. Prostate Cancer |
8.2.2. Breast Cancer |
8.2.3. Lung Cancer |
8.2.4. Head and Neck Cancer |
8.2.5. Colorectal Cancer |
8.2.6. Cervical Cancer |
8.2.7. Gynecological Cancer |
8.2.8. Others |
8.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. U.S. |
8.3.2. Canada |
8.4. North America Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029 |
8.5. North America Global Radiation Oncology Market Dynamics – Trends |
9. Europe Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
9.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
9.1.1. External Beam Radiation Therapy |
9.1.2. Internal Beam Radiation Therapy |
9.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Prostate Cancer |
9.2.2. Breast Cancer |
9.2.3. Lung Cancer |
9.2.4. Head and Neck Cancer |
9.2.5. Colorectal Cancer |
9.2.6. Cervical Cancer |
9.2.7. Gynecological Cancer |
9.2.8. Others |
9.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Italy |
9.3.5. Spain |
9.3.6. Rest of Europe |
9.4. Europe Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029 |
9.5. Europe Global Radiation Oncology Market Dynamics – Trends |
10. Asia-Pacific Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
10.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
10.1.1. External Beam Radiation Therapy |
10.1.2. Internal Beam Radiation Therapy |
10.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Prostate Cancer |
10.2.2. Breast Cancer |
10.2.3. Lung Cancer |
10.2.4. Head and Neck Cancer |
10.2.5. Colorectal Cancer |
10.2.6. Cervical Cancer |
10.2.7. Gynecological Cancer |
10.2.8. Others |
10.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Japan |
10.3.2. China |
10.3.3. India |
10.3.4. ASEAN |
10.3.5. Rest of Asia-Pacific |
10.4. Asia-Pacific Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029 |
10.5. Asia-Pacific Global Radiation Oncology Market Dynamics – Trends |
11. Latin America Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
11.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.1.1. External Beam Radiation Therapy |
11.1.2. Internal Beam Radiation Therapy |
11.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Prostate Cancer |
11.2.2. Breast Cancer |
11.2.3. Lung Cancer |
11.2.4. Head and Neck Cancer |
11.2.5. Colorectal Cancer |
11.2.6. Cervical Cancer |
11.2.7. Gynecological Cancer |
11.2.8. Others |
11.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Argentina |
11.3.3. Rest of Latin America |
11.4. Latin America Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029 |
11.5. Latin America Global Radiation Oncology Market Dynamics – Trends |
12. Middle East and Africa Global Radiation Oncology Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Million) |
12.1. Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.1.1. External Beam Radiation Therapy |
12.1.2. Internal Beam Radiation Therapy |
12.2. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Prostate Cancer |
12.2.2. Breast Cancer |
12.2.3. Lung Cancer |
12.2.4. Head and Neck Cancer |
12.2.5. Colorectal Cancer |
12.2.6. Cervical Cancer |
12.2.7. Gynecological Cancer |
12.2.8. Others |
12.3. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Saudi Arabia |
12.3.2. GCC Countries |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Global Radiation Oncology Market - Opportunity Analysis Index, By Type, Application and Country, 2023 - 2029 |
12.5. MEA Global Radiation Oncology Market Dynamics – Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Type Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Varian Medical Systems, Inc. |
13.2.2. Elekta AB |
13.2.3. Accuray Incorporated |
13.2.4. IBA Radiopharma Solutions |
13.2.5. BD (Becton, |